Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Exp Cell Res

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    October 2017
  1. ZHU S, Wang X, Wang J, Lin J, et al
    CD21lo/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T cell responses.
    Exp Cell Res. 2017 Oct 17. pii: S0014-4827(17)30561.
    PubMed     Text format     Abstract available


  2. DE S, Das S, Mukherjee S, Das S, et al
    Establishment of Twist-1 and TGFBR2 as direct targets of microRNA-20a in Mesenchymal to Epithelial Transition of Breast Cancer Cell-line MDA-MB-231.
    Exp Cell Res. 2017 Oct 4. pii: S0014-4827(17)30532.
    PubMed     Text format     Abstract available


    September 2017
  3. CASCIONE M, De Matteis V, Toma CC, Pellegrino P, et al
    Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells.
    Exp Cell Res. 2017 Sep 19. pii: S0014-4827(17)30500.
    PubMed     Text format     Abstract available


    August 2017
  4. HOU MF, Luo CW, Chang TM, Hung WC, et al
    The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
    Exp Cell Res. 2017 Aug 24. pii: S0014-4827(17)30450.
    PubMed     Text format     Abstract available


  5. YAN N, Xu L, Wu X, Zhang L, et al
    GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Exp Cell Res. 2017 Aug 18. pii: S0014-4827(17)30435.
    PubMed     Text format     Abstract available


  6. XIANG Y, Liao XH, Yao A, Qin H, et al
    MRTF-A-miR-206-WDR1 form feedback loop to regulate breast cancer cell migration.
    Exp Cell Res. 2017 Aug 17. pii: S0014-4827(17)30434.
    PubMed     Text format     Abstract available


    July 2017
  7. TVEITARAS MK, Reigstad I, Leiss L, Reed RK, et al
    Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses.
    Exp Cell Res. 2017 Jul 19. pii: S0014-4827(17)30393.
    PubMed     Text format     Abstract available


  8. SMUCZEK B, Santos ES, Siqueira AS, Pinheiro JJV, et al
    The laminin-derived peptide C16 regulates GPNMB expression and function in breast cancer.
    Exp Cell Res. 2017 Jul 5. pii: S0014-4827(17)30359.
    PubMed     Text format     Abstract available


    May 2017
  9. YI Z, Yang D, Liao X, Guo F, et al
    PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer.
    Exp Cell Res. 2017 May 18. pii: S0014-4827(17)30296.
    PubMed     Text format     Abstract available


  10. XIANG Y, Liao XH, Yu CX, Yao A, et al
    MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3.
    Exp Cell Res. 2017 May 9. pii: S0014-4827(17)30272.
    PubMed     Text format     Abstract available


  11. XIE D, Liu Z, Wu J, Feng W, et al
    The effects of activin A on the migration of human breast cancer cells and neutrophils and their migratory interaction.
    Exp Cell Res. 2017 May 4. pii: S0014-4827(17)30267.
    PubMed     Text format     Abstract available


  12. PERRI M, Caroleo MC, Liu N, Gallelli L, et al
    9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models.
    Exp Cell Res. 2017;354:25-30.
    PubMed     Text format     Abstract available


    March 2017
  13. PATEL BB, Ackerstaff E, Serganova IS, Kerrigan JE, et al
    Tumor stroma interaction is mediated by monocarboxylate metabolism.
    Exp Cell Res. 2017;352:20-33.
    PubMed     Text format     Abstract available


    February 2017
  14. GKRETSI V, Stylianou A, Stylianopoulos T
    Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, beta-catenin and urokinase-plasminogen activator (uPA).
    Exp Cell Res. 2017 Feb 13. pii: S0014-4827(17)30064.
    PubMed     Text format     Abstract available


    December 2016
  15. DHO SH, Kim JY, Lee KP, Kwon ES, et al
    STAT5A-mediated NOX5-L expression promotes the proliferation and metastasis of breast cancer cells.
    Exp Cell Res. 2016 Dec 26. pii: S0014-4827(16)30434.
    PubMed     Text format     Abstract available


  16. IRAVANI O, Bay BH, Yip GW
    Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1.
    Exp Cell Res. 2016 Dec 23. pii: S0014-4827(16)30428.
    PubMed     Text format     Abstract available


    November 2016
  17. CEPEDA MA, Pelling JJ, Evered CL, Leong HS, et al
    The cytoplasmic domain of MT1-MMP is dispensable for migration augmentation but necessary to mediate viability of MCF-7 breast cancer cells.
    Exp Cell Res. 2016 Nov 23. pii: S0014-4827(16)30391.
    PubMed     Text format     Abstract available


    September 2016
  18. ALIMIRAH F, Peng X, Gupta A, Yuan L, et al
    Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
    Exp Cell Res. 2016 Sep 27. pii: S0014-4827(16)30243.
    PubMed     Text format     Abstract available


    August 2016
  19. RADDE BN, Ivanova MM, Mai HX, Alizadeh-Rad N, et al
    Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells.
    Exp Cell Res. 2016 Aug 8. pii: S0014-4827(16)30235.
    PubMed     Text format     Abstract available


    July 2016
  20. SENGUPTA D, Deb M, Rath SK, Kar S, et al
    DNA methylation and not H3K4trimethylation dictates the expression status of miR-152gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Exp Cell Res. 2016 Jul 27. pii: S0014-4827(16)30211.
    PubMed     Text format     Abstract available


    May 2016
  21. DINICOLA S, Fabrizi G, Masiello MG, Proietti S, et al
    Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement.
    Exp Cell Res. 2016 May 26. pii: S0014-4827(16)30111.
    PubMed     Text format     Abstract available


  22. DODDAPANENI R, Patel K, Chowdhury N, Singh M, et al
    Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
    Exp Cell Res. 2016 May 10. pii: S0014-4827(16)30110.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: